![]() |
市場調查報告書
商品編碼
1930066
全球脈搏血氧儀市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測(2026-2034)Pulse Oximeters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球脈搏血氧儀市場規模為24.6億美元。在本報告涵蓋的預測期內,預計該市場將在2026年成長至25.9億美元,並在2034年達到40億美元,2026年至2034年的年複合成長率(CAGR)為5.60%。北美地區在2025年佔據市場主導地位,市場佔有率達40.70%,這得益於其先進的醫療基礎設施、患者監護技術的廣泛應用以及主要製造商的強大實力。由於慢性呼吸系統疾病盛行率的上升以及家用醫療設備的日益普及,預計美國脈搏血氧儀市場將顯著成長。
脈搏血氧儀是一種非侵入性醫療設備,用於監測血氧飽和度,這是檢測低氧血症的關鍵指標。低氧血症若不及時診斷,可能導致嚴重的併發症,例如急性呼吸衰竭。氣喘、慢性支氣管炎、慢性阻塞性肺病(COPD)、急性呼吸窘迫症候群(ARDS)、充血性心臟衰竭和貧血等疾病顯著提高了在醫院和家庭醫療保健環境中進行血氧飽和度監測的臨床重要性。
市場動態
心血管和呼吸系統疾病盛行率的不斷上升仍然是市場成長的主要驅動力。心臟衰竭和慢性呼吸系統疾病,尤其是在老年族群中,顯著促進了2025年脈搏血氧儀的普及。老年患者發生氧飽和度下降的風險更高,這導致脈搏血氧儀在家庭持續監測中的應用日益廣泛。
在新冠肺炎疫情期間,脈搏血氧儀的需求激增,因為它們成為監測感染患者的必需品。然而,從2022年和2023年開始,由於緊急需求下降,市場經歷了暫時的下滑。儘管如此,慢性病管理和預防性篩檢措施仍將持續支撐市場的長期成長。
市場趨勢
市場參與者致力於併購和產品創新,以增強其競爭地位。 Masimo 和 Medtronic 等公司不斷拓展其產品線,推出先進的、獲得 FDA 批准的血氧飽和度測量解決方案。指尖式和無線設備的推出提高了患者的便利性,擴大了其在家庭醫療保健和門診環境中的應用。
同時,監管機構對新生兒先天性心臟病篩檢的重視,以及在麻醉和手術過程中日益使用血氧儀,都有助於維持醫療機構的穩定需求。
市場成長驅動因素
慢性呼吸系統疾病(如 COPD、氣喘、睡眠呼吸中止症和肺癌)盛行率的不斷上升,持續推動市場擴張。氧飽和度監測在診斷和疾病管理中發揮非常重要的作用,尤其是在醫院環境中。此外,早產兒數量的增加也推動了對新生兒和兒童脈搏血氧儀的需求。
政府指南強制要求在重症監護和手術環境中進行氧飽和度監測,這進一步促進了產品的普及。一些已開發國家和發展中國家已經實施了新生兒脈搏血氧飽和度篩檢計畫,提高了其在醫療機構的使用率。
限制因子
儘管應用廣泛,但準確性方面的限制制約了市場成長。血液循環不良、皮膚色素沉著、指甲油和運動偽影等因素都會影響測量準確性。研究表明,膚色較深的患者測量結果存在不一致的情況,這引起了監管機構的關注,並促使美國食品藥物管理局(FDA)更新了相關指南。這些問題促使製造商投資改進感測器技術,但確保普遍可靠性仍然是個挑戰。
細分市場分析
依產品類型劃分:
受慢性阻塞性肺病(COPD)和氣喘住院人數不斷增加的推動,台式血氧儀將在2026年佔據 40.54%的市場佔有率。指尖式血氧儀因其便攜性和在家庭醫療保健環境中的廣泛應用,預計將快速成長。
依技術劃分:
傳統血氧儀將在2026年佔據 79.15%的市場佔有率,反映出醫院對有線監測系統的強勁需求。智慧血氧儀因其無線連接和遠端患者監測功能而日益普及。
依年齡層劃分:
受慢性呼吸系統疾病和心血管疾病高發生率的推動,成年人將在2026年佔總需求的92.28%。由於氣喘發病率上升和新生兒篩檢計畫的廣泛應用,兒科應用不斷成長。
依最終使用者劃分:
受持續病患監測需求的驅動,醫院和門診手術中心預計在2026年將佔據62.93%的市場佔有率。由於人們意識的提高和設備的普及,家庭醫療保健成為一個高成長領域。
區域考察
北美預計將保持領先地位,在先進的監測技術和強大的製造商實力推動下,2025年市場規模將達到10億美元,2026年將達到10.5億美元。歐洲將緊隨其後,這主要得益於強制性新生兒篩檢計畫和不斷擴大的醫療基礎設施。亞太地區預計將在2034年之前實現最快成長,這主要得益於醫療保健投資的增加、疾病意識的提高以及中國、印度和日本醫院容量的擴大。
主要公司
市場上的主要公司包括GE HealthCare、Masimo、Medtronic、Koninklijke Philips N.V.、NIHON KOHDEN CORPORATION、Nonin。這些公司致力於創新、獲得監管部門批准以及建立全球分銷網路,以保持其競爭優勢。
分析
本報告對脈搏血氧儀市場進行了全面分析,涵蓋2025年、2026年和2034年的市場規模,以及市場趨勢、細分、區域展望、競爭格局和新冠疫情的影響。報告還深入分析了技術進步、監管環境以及策略性舉措(例如併購和新產品發布),這些因素都將影響市場動態。
The global pulse oximeter market was valued at USD 2.46 billion in 2025. As per the report timeline, the market is projected to grow to USD 2.59 billion in 2026 and further reach USD 4.00 billion by 2034, registering a CAGR of 5.60% during the 2026-2034 forecast period. North America dominated the market with a 40.70% share in 2025, supported by advanced healthcare infrastructure, high adoption of patient monitoring technologies, and a strong presence of key manufacturers. The U.S. pulse oximeters market is expected to show notable expansion, supported by the rising prevalence of chronic respiratory disorders and the increasing use of home healthcare devices.
Pulse oximeters are non-invasive medical devices used to monitor blood oxygen saturation levels, a critical parameter for detecting hypoxemia. Hypoxemia, if left undiagnosed, can lead to severe complications such as acute respiratory failure. Conditions including asthma, chronic bronchitis, COPD, ARDS, congestive heart failure, and anemia have significantly increased the clinical importance of oxygen saturation monitoring in both hospital and homecare settings.
MARKET DYNAMICS
The increasing prevalence of cardiovascular and respiratory disorders remains a key driver of market growth. In 2025, heart failure and chronic respiratory diseases contributed substantially to device adoption, particularly among the aging population. Elderly patients are more susceptible to oxygen desaturation, which has increased the use of pulse oximeters for continuous and home-based monitoring.
Demand surged during the COVID-19 pandemic as pulse oximeters became essential for monitoring infected patients. However, after 2022 and 2023, the market experienced a temporary decline due to reduced emergency demand. Despite this, long-term growth remains supported by chronic disease management and preventive screening initiatives.
MARKET TRENDS
Market players are increasingly focusing on mergers, acquisitions, and product innovation to strengthen their competitive position. Companies such as Masimo and Medtronic have continued to expand their portfolios with advanced and FDA-approved oximetry solutions. The introduction of fingertip and wireless devices has improved patient convenience and expanded usage in home healthcare and ambulatory settings.
In parallel, regulatory emphasis on newborn screening for congenital heart defects and increased use of oximeters during anesthesia and surgery have contributed to stable institutional demand.
MARKET GROWTH FACTORS
The rising burden of chronic respiratory diseases such as COPD, asthma, sleep apnea, and lung cancer continues to support market expansion. Oxygen saturation monitoring plays a critical role in diagnosis and disease management, particularly in hospital environments. Additionally, the increasing number of preterm births has boosted demand for neonatal and pediatric pulse oximeters.
Government guidelines mandating oxygen monitoring in critical care and surgical settings have further strengthened product adoption. Pulse oximetry screening programs for newborns have been implemented across several developed and developing countries, increasing institutional usage.
RESTRAINING FACTORS
Despite widespread adoption, limitations related to accuracy have restrained market growth. Factors such as poor circulation, skin pigmentation, nail polish, and motion artifacts can affect reading precision. Studies have highlighted discrepancies in readings among patients with darker skin tones, leading to regulatory scrutiny and updated FDA guidelines. These concerns have encouraged manufacturers to invest in improved sensor technologies but remain a challenge for universal reliability.
SEGMENTATION ANALYSIS
By Product Type:
Tabletop oximeters dominated the market with a 40.54% share in 2026, driven by high hospital admissions for COPD and asthma. Fingertip oximeters are expected to grow rapidly due to their portability and increased use in homecare environments.
By Technology:
Conventional oximeters accounted for 79.15% of the market in 2026, reflecting strong demand for wired monitoring systems in hospitals. Smart oximeters are gaining traction due to wireless connectivity and remote patient monitoring capabilities.
By Age Group:
Adults represented 92.28% of total demand in 2026, supported by higher prevalence of chronic respiratory and cardiovascular disorders. Pediatric adoption is increasing due to rising asthma incidence and neonatal screening programs.
By End User:
Hospitals and ambulatory surgical centers held a 62.93% market share in 2026, supported by continuous patient monitoring needs. Home healthcare is emerging as a high-growth segment due to increasing awareness and device availability.
REGIONAL INSIGHTS
North America led the market with a valuation of USD 1.00 billion in 2025 and USD 1.05 billion in 2026, driven by advanced monitoring technologies and strong manufacturer presence. Europe followed, supported by mandatory newborn screening programs and healthcare infrastructure expansion. Asia Pacific is expected to record the fastest growth through 2034, fueled by rising healthcare investments, increasing disease awareness, and expanding hospital capacity in China, India, and Japan.
KEY INDUSTRY PLAYERS
Leading companies operating in the market include GE HealthCare, Masimo, Medtronic, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, and Nonin. These players focus on innovation, regulatory approvals, and global distribution to maintain competitiveness.
REPORT COVERAGE
The report provides a comprehensive analysis of the pulse oximeter market, covering market size for 2025, 2026, and 2034, along with trends, segmentation, regional outlook, competitive landscape, and the impact of COVID-19. It includes insights into technological advancements, regulatory developments, and strategic initiatives such as mergers, acquisitions, and new product launches influencing market dynamics.
CONCLUSION
The global pulse oximeter market shows steady and sustained expansion across the report period, supported by the growing burden of chronic respiratory and cardiovascular diseases and the increasing need for continuous patient monitoring. With the market valued at USD 2.46 billion in 2025, rising to USD 2.59 billion in 2026, and projected to reach USD 4.00 billion by 2034, growth is primarily driven by hospital-based demand and the rising adoption of home healthcare monitoring devices. The dominance of North America with a 40.70% market share in 2025 reflects strong healthcare infrastructure and early adoption of advanced monitoring technologies. Continued technological innovation, regulatory support for screening and monitoring, and expanding awareness of early hypoxemia detection are expected to sustain market momentum throughout the forecast period.
Segmentation By Product Type
By Technology
By Age Group
By End-user
By Region